Results 161 to 170 of about 280,195 (357)

Longitudinal Patterns of Fatigue in Long‐Term Survivors of Childhood and Adolescent Cancers: A Report From the Swiss Childhood Cancer Survivor Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Fatigue negatively affects quality of life. We aimed to compare the prevalence of fatigue in survivors of childhood cancer with the Swiss general population, describe longitudinal patterns of fatigue, and identify characteristics associated with persistent fatigue in survivors.
Salome Christen, Luzius Mader, André O. von Bueren, Eva Maria Tinner, Grit Sommer, Christina Schindera, Claudia E. Kuehni, Katharina Roser, Gisela Michel   +8 more
wiley   +1 more source

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma [PDF]

, 2015
Stefan K. Barta, M.S. Samuel, Xiaonan Xue, D. Wang, J. Y. Lee, Nicolas Mounier, Josep‐María Ribera, Michele Spina, Umberto Tirelli, RA Weiss, Lionel Galicier, François Boué, Richard F. Little, Kieron Dunleavy, Wyndham H. Wilson, Christoph Wyen, Scot C. Remick, Lawrence D. Kaplan, Lee Ratner, Ariela Noy, Joseph A. Sparano   +20 more
openalex   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Disseminated Toxoplasmosis in a Patient with Non-Hodgkin Lymphoma

, 2009
M Herold, Reto Kühne, M. Vosberg, Sonja Ostheeren-Michaelis, Peter Vogt, Urs Karrer   +5 more
openalex   +1 more source

Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort [PDF]

, 2009
Eva Erber, Gertraud Maskarinec, Unhee Lim, Laurence N. Kolonel   +3 more
openalex   +1 more source

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

Science Translational Medicine, 2016
C. Turtle, L. Hanafi, C. Berger, M. Hudecek, B. Pender, E. Robinson, R. Hawkins, Colette N. Chaney, S. Cherian, Xueyan Chen, L. Soma, B. Wood, Daniel H. Li, S. Heimfeld, S. Riddell, D. Maloney   +15 more
semanticscholar   +1 more source

A Multiple‐Model‐Informed Drug‐Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 572-582, March 2025.
ABSTRACT The antitumor efficacy of an intratumoral injection of a genetically engineered oncolytic vaccinia virus carrying human IL‐7 and murine IL‐12 genes (hIL‐7/mIL‐12‐VV) was demonstrated in CT26.WT‐bearing mice. In the CT26.WT‐bearing mouse model, the efficacy of the combination of hIL‐7/mIL‐12‐VV plus the anti‐programmed cell death protein (PD)‐1
Akihiro Yamada, Mary P. Choules, Frances A. Brightman, Shigeru Takeshita, Shinsuke Nakao, Nobuaki Amino, Takeshi Nakayama, Masato Takeuchi, Kanji Komatsu, Fernando Ortega, Hitesh Mistry, David Orrell, Christophe Chassagnole, Peter L. Bonate   +13 more
wiley   +1 more source

Non-Hodgkin Lymphoma Presenting as Tonsillitis

, 2020
Lígia Barbosa Torres, Daniel Torres, Ana Cardoso   +2 more
openalex   +1 more source

Autologous Transplantation for Transformed Non-Hodgkin Lymphoma Using an Yttrium-90 Ibritumomab Tiuxetan Conditioning Regimen [PDF]

, 2014
Matthew Mei, Mariëlle J. Wondergem, Joycelynne Palmer, Avichai Shimoni, Justin Hasenkamp, Ni‐Chun Tsai, Jennifer Simpson, Auayporn Nademanee, Andrew Raubitschek, Stephen J. Forman, Amrita Krishnan   +10 more
openalex   +1 more source

Model‐Informed Drug Development of Subcutaneous Nivolumab: Comparison of Pharmacokinetic Analysis Methodologies Using Clinical Trial Simulation

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT A subcutaneous formulation of nivolumab was evaluated in the phase III study CheckMate 67T (NCT04810078). The co‐primary pharmacokinetic exposure endpoints, time‐averaged serum concentration over the first 28 days (Cavgd28), and steady‐state trough concentration (Cminss) were determined through population pharmacokinetic analysis as compared ...
Yue Zhao, Heather Vezina, Zheyi Hu, Anna Kondic, Li Zhu, Amit Roy   +5 more
wiley   +1 more source